Literature DB >> 32727783

Ginseng Seed Oil Inhibits the Growth of Estrogen Receptor-positive Breast Cancer Cells.

Tae Hun Kim1, Sang-Chul Kwon2, Jeong Nam Kim3, Ji-Hye Yoon1, Sung-Gook Cho4.   

Abstract

BACKGROUND/AIM: Although ginseng seed oil (GSO) appears to have various roles in the body, its anti-cancer effect has not been investigated. Tamoxifen is widely used to treat estrogen receptor-positive (ER+) breast cancer but shows adverse effects with drug resistance. This study investigated the effect of GSO in ER+ breast cancer cell growth.
MATERIALS AND METHODS: Cell viability assays, western blots and Annexin V staining were conducted to examine cell viability and apoptosis. The synergistic effect of tamoxifen in combination with GSO or oleic acid (OA) was determined.
RESULTS: GSO and OA caused apoptosis of MCF-7 ER+ breast cancer cells and had synergistic effects with tamoxifen in inhibiting tamoxifen-resistant MCF-7 (MCF-7TAMR) ER+ breast cancer cell growth.
CONCLUSION: GSO may block ER+ breast cancer recurrence in combination with tamoxifen. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  ER+; Ginseng seed oil; breast cancer; oleic acid; tamoxifen

Mesh:

Substances:

Year:  2020        PMID: 32727783     DOI: 10.21873/anticanres.14458

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  1 in total

1.  Combinatorial treatments of tamoxifen and SM6Met, an extract from Cyclopia subternata Vogel, are superior to either treatment alone in MCF-7 cells.

Authors:  Lorinda van Dyk; Nicolette J D Verhoog; Ann Louw
Journal:  Front Pharmacol       Date:  2022-09-22       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.